Current models suggest that BMP-9/-10-ALK1-endoglin-SMAD target genes do inhibit angiogenesis [212,213] required to protect against HHT development (Figure 3). The gene discussed is ACVRL1; the disease is hereditary hemorrhagic telangiectasia.